Opin vísindi

Fletta eftir DOI "10.1038/s41375-024-02153-6"

Fletta eftir DOI "10.1038/s41375-024-02153-6"

Röðun: Raða: Niðurstöður:

  • Icon
    Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia 
    Dam, Merete; Centanni, Maddalena; Friberg, Lena E.; Centanni, Daniel; Karlsson, Mats O.; Stensig Lynggaard, Line; Johannsdottir, Inga Maria; Wik, Hilde Skuterud; Malmros, Johan; Vaitkeviciene, Goda Elizabeta; Griskevicius, Laimonas; Hallböök, Helene; Jónsson, Ólafur Gísli; Overgaard, Ulrik; Schmiegelow, Kjeld; Hansen, Stefan Nygaard; Heyman, Mats; Albertsen, Birgitte Klug (2024)
    Asparaginase is an essential component of acute lymphoblastic leukemia (ALL) therapy, yet its associated toxicities often lead to treatment discontinuation, increasing the risk of relapse. Hypersensitivity reactions include clinical allergies, silent ...